Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.
Pelage Pharmaceuticals has raised $120.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Pelage Pharmaceuticals's investors include ARCH Venture Partners, Google Ventures, Visionary Venture Fund, Main Street Advisors, YK Bioventures.
Pelage Pharmaceuticals is headquartered in Los Angeles, United States.
Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.
Pelage Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pelage Pharmaceuticals — Funding & Investors." VCBacked, October 15, 2025, https://www.vcbacked.co/company/pelage-pharmaceuticals. Accessed July 19, 2026.
VCBacked. (2025). Pelage Pharmaceuticals — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/pelage-pharmaceuticals
{{cite web |title=Pelage Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/pelage-pharmaceuticals |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated